APA (7th ed.) Citation

K, M., J, V., C, S., J, G., Y, P., G, M., . . . A, A. (2026). An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults. Human vaccines & immunotherapeutics, 22(1), 2616144. https://doi.org/10.1080/21645515.2026.2616144

Chicago Style (17th ed.) Citation

K, McElwee, Vojicic J, Sabharwal C, Ginis J, Peng Y, Mircus G, Watson W, and Anderson A. "An Overview of the Clinical Development of the 20-valent Pneumococcal Conjugate Vaccine in Adults." Human Vaccines & Immunotherapeutics 22, no. 1 (2026): 2616144. https://doi.org/10.1080/21645515.2026.2616144.

MLA (9th ed.) Citation

K, McElwee, et al. "An Overview of the Clinical Development of the 20-valent Pneumococcal Conjugate Vaccine in Adults." Human Vaccines & Immunotherapeutics, vol. 22, no. 1, 2026, p. 2616144, https://doi.org/10.1080/21645515.2026.2616144.